CE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Celanese Corp (CE) is not a strong buy for a beginner investor with a long-term focus at this time. The stock's technical indicators show a bearish trend, and the company's financial performance in the latest quarter reveals significant declines in revenue, net income, and EPS. While some analysts have raised price targets and see potential stabilization in certain segments, the lack of strong positive catalysts and weak financials suggest holding off on investment until clearer signs of recovery emerge.
The technical indicators are bearish. The MACD histogram is negative and expanding (-1.05), indicating downward momentum. RSI is at 25.044, suggesting the stock is approaching oversold territory but not yet signaling a reversal. Moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 49.149), with resistance levels at R1: 60.051 and R2: 63.419.
Some analysts have raised price targets, with BofA and Citi maintaining Buy ratings and highlighting potential stabilization in key segments like acetyls and engineered materials. Jefferies upgraded the stock to Buy, citing operating leverage to a demand cycle and potential benefits from cumulative stimulus.
The company's financial performance in Q4 2025 was weak, with revenue down 7% YoY, net income down 100.99% YoY, and EPS down 100.97% YoY. Gross margin also declined significantly. Technical indicators suggest a bearish trend, and options data reflects a slightly bearish sentiment. There is no recent news or significant trading activity from insiders, hedge funds, or Congress to support a bullish case.
In Q4 2025, Celanese reported a 7% YoY drop in revenue to $2.204 billion. Net income fell by 100.99% YoY to $19 million, and EPS dropped by 100.97% YoY to $0.17. Gross margin decreased to 17.38%, down 17.43% YoY. These results indicate a challenging operating environment with declining profitability.
Analyst sentiment is mixed. While some firms like BofA, Citi, and Jefferies have raised price targets and issued Buy ratings, others like RBC, JPMorgan, and UBS maintain Neutral ratings, citing challenging operating conditions and weak demand growth. Price targets range from $53 to $86, with an average around $63, indicating moderate upside potential.
